The Founder Signal Kit · Self-guided
At the pre-market stage there is no clinical evidence to weigh, so investors and surgeons weigh you. This kit measures how you score on that reading, and repairs it in the right order. Three scored diagnostics, a repair system, a ninety-day plan. One afternoon to start.
As co-founder of InSpine, a Dutch distribution company in spinal implants and an incubator for promising MedTech, I have read pitches from the receiving side for years. Flaws reveal themselves immediately, and the founder is usually the first place they show. The three that made it through became EIT (acquired by Johnson and Johnson in 2019, the implants sell today as DePuy Synthes Conduit), Cresco Spine and Atraxon Biotech.
Nobody tells a founder why the term sheet never came. The investor searched your name, read your profile, asked an AI assistant about your company, found four versions of the same story, and quietly moved on. This kit is the instrument set I wish those nine founders had used before they pitched.
How visible am I, really?
Twelve scored questions across the four signals a stranger reads: track record, problem fluency, peer trust, current direction. A score from 0 to 36 and the exact signal to repair first.
What does my LinkedIn tell a stranger?
Six profile sections, each scored 0 to 3, a total from 0 to 18 with three bands: invisible, readable with gaps, working. Every low score points to its own repair section.
What does ChatGPT say about me?
Investors now ask AI assistants who you are before the first call. Four questions that surface what the machine answers about you, your company and your category, with a day-zero log to measure against.
What do I fix first?
The triage that turns your scores into a work list. The yesterday-list of active damage, the this-week list, the polish list. No guessing about where to start.
How do I rebuild?
The positioning line with three room translations, the three-layer profile rebuild with fill-in templates, the Featured section trio, and twelve content angles that stay inside MDR Article 7 at the pre-market stage.
How do I keep it alive?
Ninety minutes a week, a weekly planner, and a day-90 remeasure of all three diagnostics. The delta is your proof that signal compounds.
EUR 349
excl. VAT · one-time · instant access
Instant access after payment: the full kit as an online document plus the print-ready PDF with all six worksheets.
Buy the Kit · EUR 349 excl. VATLaunch week, until Tuesday 14 July: readers of The Operating Table buy at EUR 249 excl. VAT through a link that exists only inside the newsletter. It is not on this page and it is not automatic. Subscribe free and the launch edition brings you the link. Want the deeper work instead? The Congruence Audit reads all four surfaces for you.
The method is not theoretical. Nancy Lamerigts, MD PhD, built company signal at EIT (acquired by Johnson and Johnson, the implants sell today as DePuy Synthes Conduit), Cresco Spine (FDA cleared, launching globally in 2026) and Atraxon Biotech, and now applies the same mechanism to founder visibility. She has judged MedTech pitches from the receiving side as co-founder of InSpine. The kit is that experience, turned into a protocol you can run without her.